Speakers
Elsa Abranches, Chief Scientific Officer, ViSync Technologies
Esam Abualrous, Principal Scientist, Schrödinger
Myriam Adam, Senior director R&D and Cell line engineering, KBI Biopharma
Khalid Al-Kinani, Professor and Dept. Chair, University of Baghdad
Juan Carlos Almagro, R&D Director, UDIBI-National Polytechnique Institute
Manal Almutairi, Senior Expert Clinical Assessor, sfda
Luis Alvarez-Vallina, H12O-CNIO Cancer Immunotherapy Clinical Research Unit, Spanish National Cancer Research Centre (CNIO)
Antonio Angelastro, Senior Scientist, AstraZeneca
Can Araman, Senior Manager, Merck KGaA
Marcelino Arciniega Castro, Head of Structural Biology and Data Analysis, JJP Biologics
Dr. Joshua Armitano, Head of Operations, ExcellGene SA
Baptiste Balbuena, Application Engineer Downstream, Merck Group
Jitin Bali, Business Development Manager, Numaferm GmbH
Abhishek Bansod, Senior Safety Scientist, Roche
Michal Bassani-Sternberg, Group Leader, Antigen Discovery/Head Of Immunopeptidomics Unit, Department Of Oncology, University of lausanne
Cornelia Baumgartner, Clinical Operations Manager, T-CURX GmbH
Fabrice Bayard, Sr. Manager - Business Management, Thermo Fisher Scientific
Alain Beck, Senior Director, Centre d'Immunologie Pierre Fabre
Stephen Beers, Professor of Immunology and Immunotherapy, University of southampton
Julia Behnke, CEO and Co-Founder, ingineeon | advanced immunotherapeutics
Andreas Beilhack, Professor, Universitatsklinikum Wurzburg
Jean-François Bellec, Biologics Market Development Manager, Bio-Techne
Nicola Beltraminelli, Chief Development Officer, Head of RED, INNATE PHARMA
Edwige Beng-Louka, Senior scientist, Novartis Pharma AG
Rotem Bennet, Mindware Health
Martin Bertschinger, Director Drug Substance Development, Ichnos Glenmark Innovation
Juliana Bessa, Translational Biomarker Strategy Lead, Oncology, Roche
Dimitri Bieli, EVP Molecular Biology, Mabylon AG
Eli Bixby, Co-Founder & ML Lead, Cradle Bio
Vladimir Bobkov, Principal Scientist, argenx
Ellen Boelen, Director Business Development, ImmuneSpec BV
Cedric Bogaert, Chief Executive Officer, myNEO Therapeutics
Sara Bonetti, Senior Scientist, Salipro Biotech AB
Louis Boon, Chief Scientific Officer and Board member JJP Biologics, JJP Biologics
Gitta Boons, Principal Data Scientist, myNEO Therapeutics
Leonard Both, ATMP assessor, Swissmedic
Laure Bouchez, Executive in Residence, General Inception
Frederic Bouder, Professor Of Risk Management, University of Stavanger
Caroline Boulliat, md, Genchrome
Helena Braet, Postdoc, ETH Zürich
Diego Braguglia, GP, Vi Partners
Arnd Brandenburg, Senior Scientific Account Manager, Genedata
Stefan Braun, Head of Laboratory, Merck Life Science KGaA
Sebastian Breuer, Innovation Lead & Preclinical Project Leader at pRED, Roche Diagnostics GmbH
Sascha Oliver Bucher, Co-Founder and Partner, Forty51 Ventures AG
Luigi Buonaguro, MD, Innovative Immunological Models Unit, National Cancer Institute
Floris Burgering, Global Manufacturing Network Program and Risk manager, Genentech/Roche
Claudio Calvaruso, Associate Scientist, Merck Serono
Michela Castellani-Kleinschroth, Head of MS&T, SKAN AG
Regis Cebe, Senior Principal Scientist, Novartis
Maurizio Ceppi, Chief Scientific Officer, Transgene SA
Prasun Chakraborty, CEO and Founder, Genevation LTD
Alina Charter, VP, Head of Pricing, Market Access and Policy, Alnylam
barry chester, director, pfizer
Sean Keng Rui Chia, Senior Scientist, Bioprocessing Technology Institute, Agency for Science, Technology, and Research
Yok Hian Chionh, Director of Protein Sciences, GenScript
Anandi Chowdhury, Ph.D. Candidate, Indian Institute of Technology Delhi
Adrian Chrastina, Associate Professor, Proteogenomics Research Institute for Systems Medi
Michaela Cohrs, PhD student, Ghent University
Sam Cooper, Co-Founder, Phenomic AI
Paul Cornes, Oncologist, The European School of Oncology
Eunice Costa, Director Inhalation and Advanced Drug Delivery, Hovione
Pedro Cruz, CTOO, IBET
Camille Dagallier, Senior Formulation Scientist, Sanofi
Laura Daley, Senior Director, Molecular & Cellular Biology, Catalent Pharma Solutions
Luminita Damian, BDM, Cytiva
Shahrad Daraeikia, Director of Business Development, Mosaic Biosciences
Roberto De Luca, Head of Therapeutic Antibodies, Philochem
Carmen De Santo, Cruk New Investigator Fellow, Cancer Research UK
Julie Deckers, Senior Scientist Preclinical Product Development, argenx
Fabienne DECKERT, Founder and Managing Director, COMPLYOMICS Sàrl
Brad Delaney, Associate Manager, Business Development, Nona Biosciences
Gundo Diedrich, Vice President, MacroGenics
Susanne Diehl, Global Program Head, Novartis Pharma AG
Michaela Dinboeck, Head Patient Engagement, Novartis
Alexander Dityatev, Group Leader, German Ceter for Neurodegenerative Diseases (DZNE)
Harsha Doddihal, Global Clinical Lead, Tellix
François Dohet, VP BD@Sales, LiveDrop
Patrick Doonan, Director of Antibody Engineering, Ailux
Joan D'souza, Local QPPV, Independent PV Expert
Stefan Dübel, Director, Technical University of Braunschweig
Michael Dyson, Vice President - Antibody Discovery & Engineering, Ichnos Glenmark Innovation
Hilmar Ebersbach, CSO, Immunos Therapeutics
Anselm Ebert, Business Development Director, H and T Presspart Manufacturing
Patrick Eckenstein, Clinical Environmental Sustainability Lead, Novartis
Stefan Eichmüller, Head of Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ)
Nora Eifler, Head Drug Substance Project Management, Novartis
Marisa Elliott, Director of Business Development, Therapeutics, Oligo Factory, Inc.
Elisabeth Engelsberger, Project Leader - Preclinical Development, Bioconjugates, Lonza
Mourad Farouk Rezk, Independent Global Biotech and Biosimilars Executive, Independent
Matthias Feige, Technical University Munich
Christian Fellows, Managing Director, Healthcare team, Inflexion Private Equity
Nadia Fernandez, Industry Clinical Collaboration Leader, F. Hoffmann-La Roche Ltd.
Alejandro Fernandez Martell, Principal Scientist, Global Process Development, Lonza
Pierre Ferré, Chief Operating Officer, Compugen Ltd
alexandra ferrier, senior medicinal chemist, Laboratoires Pierre Fabre
Laurens Finsy, Director Clinical Operattions, Cabaletta Bio
Gregory Fiore, Member Board Of Directors, Eterna Therapeutics
Gregory Fiore, Former CEO, Exacis Biotherapeutics
Ralphie Fiorenza, Product Manager, Collaborative Drug Discovery Inc
Kevin Fitzgerald, Chief Scientific Officer, Epsilogen
Nuno Fontes, SVP and Head of Global CMC, WuXi Vaccines
Dan Foxler, Head of Cell Biology, LabGenius Tx
Linnea Franssen, Principal Modelling & Simulation Scientist, Roche
Francois-Xavier Frapaise, CMO, Bio-Sourcing
Tim Fugmann, CSO and Co-founder, Alithea Bio
Frank Gesellchen, Assay Development Manager, Sphere Bio
Felix Geyer, PhD student, TU Darmstadt
Ettore Gilardoni, Head of Mass Spectrometry, Philochem
Arnaud Goepfert, Director Protein Sciences, Bright Peak Therapeutics
Steffen Goletz, Professor, Department of Biotechnology and Biomedicine, Danish Technical University
Iris Good, Investment Committee Member, University of Cambridge Enterprise
Torbjorn Graslund, prof., KTH Royal Institute of Technology
Ulf Grawunder, Chief Executive Officer & Co-Founder, T-Curx
Christina Greitens, Doktorandin, ETH Zürich
Dr. Sherry Gu, EVP & Chief Technology Officer, WuXi Vaccines
Uwe Gudat, Chief Medical Officer, Biocon Biologics
Haotian Guo, CEO, Ailurus Bio
Lydia Gushgari, Chief of Staff, SPOC Proteomics
Claes Gustafsson, Co-Founder, ATUM BIO
Ana Isabel Gutiérrez López, Global Business Development Manager, H and T Presspart Manufacturing
Frederick Gyapon Quast, Director Business Development, FyoniBio GmbH
Thomas Hach, GPCH, Novartis
Tarik Hadi, Market Strategy Manager, Cell & Gene Therapy, Takara bio Europe
Livnat Halel, Experienced Clinical Projects Manager, Independent
Julia Harwardt, Scientist, Merck Healthcare KGaA
Luluah Hashim Husain, Global Head of Finance, Biosimilars, Biogen
Winston Haynes, VP, Computational Sciences & Engineering, LabGenius Therapeutics
Hooman Hefzi, Associate Professor, Danish Technical University
Charles Heise, Associate Director, Bioprocessing Strategy & Development, FUJIFILM Biotechnologies
Jana Hersch, Head of Corporate Scientific Engagement, Genedata
Oliver Hill, Senior Director Protein Engineering, Yumab GmbH
Axel Hohenstein, CSO, Bioassay - A Reaction Biology Company
Sebastian Hörner, Senior Scientist, BiconY Therapeutics
Thomas Huber, Athebio
Michael Huebner, Director, Country Lead EIP, Johnson & Johnson Innovation
David Hughes, Head, Global Clinical Development, Sandoz AG
James Humphrey, R&T Specialist, Croda
Melita Irving, Group Leader, University of lausanne
Elżbieta Jagielska, assistant professor, IMDiK PAN
Ruediger Jankowsky, CEO, AATec Medical GmbH
Ibo Janssens, Senior Scientist, argenx
Shashi Jatiani, Director of Strategic Partnerships, SeromYx systems
Colette Johnston, VP - Head of Product Platform Research, Enara Bio
Peter Jorgensen, Chief Executive Officer, Danish Generic and Biosimilar Medicines Industry Association (IGL)
Veronika Jotterand, Medical Director, Global Clinical Development, MSD
Valentin Junet, Senior Data Scientist, Engimmune Therapeutics AG
Otto Jurrius, General Manager, Biologic Clinical and Commercial Manufacturing, Thermo Fisher Scientific
Andrei Kamenski, Senior Data Scientist, In Silico Antibody Discovery, Novo Nordisk
Sophia Karagiannis, Professor of Translational Cancer Immunology and Immunotherapy, King's College London
Aneesh Karatt Vellatt, Chief Scientific Officer, Maxion Therapeutics
Anette Karle, Immunogenicity expert, Novartis
Marc-André Kasper, VP Chemistry and Early Discovery, Tubulis GmbH
Hans Keirstead, Chairman and CEO, AIVITA Biomedical; CEO, The Human Immunome Project
Divor Kiseljak, Chief Operating Officer, Excellgene
Eva-Maria Knoch, Senior Scientist II, AbbVie
Marianna Koga, Technical Development Lead, Tigen Pharma
Eszter Kovács, Business Development Advisor, Xpamac
Arjen Kramer, Senior Principal Scientist, Merus
Carsten Krantz, Associate Director, Novartis
Emanuel Kreidl, Senior Expert, Principal Scientist, Novartis
Mireille Krier, Senior Application Scientist Manager, OpenEye, Cadence Molecular Sciences
Jaya Krishnan, Co-founder, Genome Biologics
Radha Krishnan, Executive Director, Clinical Pathology Lead, MSD
Peter Kristensen, Professor, Aalborg University
Dan Bach Kristensen, Scientific Director, Symphogen
Philipp Kuhn, VP Services & Operations, Yumab GmbH
Anil Kumar, Business Development Manager, Kactus
Daniel Larcombe-Young, Senior Scientist, Leucid Bio
Vincent Larraillet, Senior Scientist, Roche
Mayra Latorre-Martinez, Clinical Study Assessor, Swissmedic
Heinz Läubli, Group Leader, Head of Clinical Research Oncology, University Hospital Basel
Beau le Roy, Technical Sales Supervisor, ACROBiosystems
Sergio Leal, VP, Ophthalmology Development Lead, Bayer Consumer Care AG
Tanguy Lechertier, Senior Translational Research Manager, UCL
Travis LeGuyader, CEO, Abkyu
Bernd Liedert, Founder / Consultant, BL Consulting
Dr Troy Lionberger, Chief Business Officer, A-Alpha Bio
Britta Lipinski, PhD Student, Merck Healthcare KGaA
Andre LIU MAN HIN, BIOTECH CMC LEAD, BAYER
Pasquale Lombardi, Clinical Fellow, Imperial College London
Margaux Longuespée, Project Manager Quality, EYLIO
Rémi Longuespée, Project Manager in Mass Spectrometry, Novalix
Friedemann Loos, Innovation Manager, bioRN
Christian Lotz, General Manager EMEA, Pfanstiehl GmbH
Robin Löving, CSO, Salipro Biotech AB
Marco Lucchin, Head of Life Science, WExecutive
Àngel Lucio Pereira, CEO, Tetraneuron
Rosita Lupi, ADC Platform Head, Nerviano Medical Sciences Srl
Narendra Maharaj, Head- Clinical Development, Biologics, Dr Reddys Laboratories Limited
Heather Malicki, Executive Director, Analytical Science, Minaris Advanced Therapies
Nirmal Mallick, Ph. D. Candidate, IIT Delhi
Melanie Mann, Manager of CLD Operations, Sartorius
Julie Maréchal-Jamil, Senior Director Pharmaceutical Policy, Medicines for Europe
Johanna Marines, Head of Preclinical, Mabqi
Daniela Marino, CEO, CUTISS AG
Tamás Martinek, Chief Scientic Officer, Xpamac
Aimee Mattei, Director of Immunoinformatics, EpiVax Inc
Irwin Matyjaszczyk, Senior Scientist I, Selvita S.A
Carrie Maynard, Associate Director of Commercial Development, Lightcast
Blake Mazzitelli, Principal Scientist, Maxion Therapeutics
Felix Meiser, PhD student, TU Darmstadt
Samu Melkko, Associate Director, Novartis
Fabien Menissez, Business Development Manager, Alga Biologics
Dominik Mertens, Scientific Account Manager, Genedata
Simon Messner, Director, Patient Engagement Scientific Excellence, Novartis Pharma AG
Virginia Metrangolo, Postdoc/Co-founder CSO PanTarg, University of Copenhagen
Rebecca Michael, Lonza
Lydia Michaut, Director scientific governance PK sciences, Novartis
Enkelejda Miho, Professor Of Digital Life Science Sciences, University of Applied Sciences Northwestern Switzerland
Anika Mijakovac, Expert associate/Senior researcher, Faculty of Science, University of Zagreb
DR Michel Mikhail, Expert in Global Regulatory Affairs and Governmental relations, Expert in Biosimilars, Independent
Max Mittelviefhaus, Head of Research and SKANalytix, SKAN AG
Ravishankara MN, Senior General Manager, Analytics- Function Head, Sun Pharma
Jeffrey Mocny, Vice President, Regulatory, Abzena
Kris Modig, Scientific Solutions Consultant, Benchling
Lorenzo Montrasio, Secretary General, VolRethics
Mauricio Morales-Castillo, Global Medical Associate Director Biosimilars, Abbott's Medicines Business
Guillaume Mottet, Lab Head, Sanofi
Michael Muenzberg, CEO, Targeted Soloutions
Marco Müller, PhD student, Philochem AG
Julien MUZARD, Field Application Technologist, Entegris
Srividya Narayanan, Student, Northeatern University
Lukas Naumann, Scientist - Analytical Chemistry (PAT), Roche
Leman Nur Nehri, Computational Biologist, Independent Consultant
Sarfaraz Niazi, PROFESSOR, University of Illinois
Björn Niebel, Senior Principal Scientist, Sanofi Ghent - Sanofi R&D
Caroline Noack, Senior Manager, USP Development, Novartis
Isabel Ottinger, Team Head Phd, Novartis Pharma AG
SANDIP PAGAR, Scientist (Downstream Process Development), UCB Pharma
Ravish Patel, General Manager, Kodo Life Science
Ketan Patil, Scientific Development Scientist, Twist Bioscience
Vijaya Pattabiraman, Co-founder & CTO, Bright Peak Therapeutics
Matthias Peipp, Head - Division of Antibody-Based Immunotherapy, UKSH - University Hospital Schleswig-Holstein
Kalyani Pemmaraju, Director - Operations (Formulation, Fill/Finish and Packaging), External Supply and Manufacturing, AstraZeneca
Rob Pengelly, Senior Scientist, Etcembly Ltd
Elise Pepermans, CEO, ImmuneSpec BV
Dilara Perver, Group Leader, Senior Scientist, ETH Zürich
Isabelle Petit-Topin, Team/Lab Lead in Downstream Process _ Manufacturing Science and Technology (DSP MS and T), Novartis France
Chad Pettit, Executive Director, Global Government Affairs, Amgen
Madalena Peyroteo, Scientist, F. Hoffmann-La Roche AG
Birgit Piater, Associate Scientific Director - ADC Biology, Merck Healthcare KGaA
Maria Pihlgren Bosch, Senior Director, Ichnos Glenmark Innovation, IGI
Mary Pitman, Staff Research Scientist, AI Sim, Sandbox AQ
Jamie Plant, Research Scientist, University College Dublin
Andreas Plueckthun, Professor Of Biochemistry, Director, Department Of Biochemistry, University of Zurich
Simon Plyte, CSO, Biomunex Pharmaceuticals
Carolina Pola, CEO, Stab Therapeutics
Ioana Popa-Burk, Head of Market Access Strategy, Abbott EPD
Philipp Probst, Director ADC Research, Araris Biotech AG
Emanuele Puca, Chief Operating Office, Philochem
Narasimha Pullaguri, Scientist, Hetero Biopharma Limited
Steven Quayle, Senior Vice President & Head of Research and Translational Medicine, Cue Biopharma
Andy Racher, Director of Commercial Operations, SYNGENSYS
Moutih Rafei, Full Professor, University of Montreal
Tobias Rainer, Senior Associate Scientist, Roche Diagnostics GmbH
Alexander Rau, Senior Scientist Protein Engineering, Anaveon
Katharina Reefschläger, Technical Sales Specialist Custom Antibodies, Bio-Rad
Ramona Reichenbach, Head of Managed Access & Medical Policy, Novartis
Sérgio Ribeiro, Principal Scientist in Analytical and Process Development, Tigen
Alexandra Richardson, Executive Director, Institut Clayton de Recherche
Valéry Risson, Director, RLT Value & Access International, Novartis
Johan Rockberg, Professor, KTH
Luis Rodriguez Carnero, Scientist, IQVIA
Ali Roghanian, Associate Prof in Cancer Immunotherapy, University of southampton
Thomas Rose, Head of Expression Systems, ProBioGen AG
Christine Rothe, Chief Development Officer, iOmx Therapeutics AG
Izabela Sabała, Head of Protein Engineering Laboratory, Mossakowski Medical Research Institute PAS
Nicolas Sabarth, Research Laboratory Head in Biotherapeutics Discovery and Cancer Immunology, Boehringer Ingelheim
Sreedhar Sagi, Head, Medical Affairs International Region, Sandoz
Giorgio Salciarini, Head of Sales - Technical Business Development, BSP Pharmaceuticals Spa
Stefano Sammicheli, Senior Director, Ichnos Glenmark Innovation
Aaron Sato, Chief Strategy Officer, Adimab
Ulrike Scheffler, Senior Director Business Development, Icosagen
Patrick Schmidt, Senior scientist, National Center for Tumor Diseases
Jan Schnitzer, Director, P.R.I.S.M.
Christian Schwarz, Chief Scientific Officer and Co-Founder, Numaferm
Andreas Seidl, CSO, Formycon AG
Oliver Seifert, Post-Doc, University of Stuttgart
Anyah Settle, R&D Scientist, University of Sheffield
Jae Sly, Ceo, Pathways Preclinical Partners
Claudia Soares, Lead Scientist Drug Substance, CDR-Life
Andreu Soldevila, Chief Executive Officer, SYNA therapeutics
Elizaveta Solovyeva, Senior Expert Data Scientist, AI and Computational Science, Novartis
Léa Sorret, Principal Scientist & Group Head in Formulation Development, Drug Product, Integrated Biologics, Lonza
Anissa Souidi, Scientist, Merck
Debora Souza da Costa, Biosample Project Leader, Roche
Frank Staal, Professor of Molecular Stem Cell Biology, Leiden University Medical Center (Netherlands)
Christian Stegmann, CSO, Absci GmbH
Andreas Stengl, Team Lead, Protein Engineering, Ludwig Maximilians University Munich
Pawel Stocki, Vice President of Research, Ossianix, Inc.
Rocky Strollo, Associate Professor of Endocrinology, Università San Raffaele Roma
Hristo Svilenov, Associate Professor, Technical University of Munich
Jelto Swaving, Senior Manager, Business Development, PPD clinical research business of ThermoFisher Scientific
Hamed T. Ghomi, Sowerby Lecturer, King's College - London
Jian Tang, Associate Professor, H.E.C. Montreal
Lorenz Tanner, Member of Patient Board, SAKK Swiss Group for Clinical Cancer Research
Anike Te, Chief Strategy Officer; Aegis Professor of Engineering Biology, Lucideon & University of Bristol
Bert Thomas, Senior Vice President Of Business Development, Bio-Thera Solutions
Gudrun Thorhallsdottir, Research Scientist Associate, Philochem AG
Jakub Tomala, Assistant Research Professor, John Hopkins University
Marco Traub, Chief Executive Officer, TESCT - The Trans European Stem Cell Therapy Society
Estefania Tumbaco Valarezo, CIFRE PhD student, Servier
Lorenzo Turelli, Postdoctoral Researcher, University of Strasbourg
Mikko Turunen, Chief Scientific Officer, RNatives
Jens Twellmeyer, Associate Director Science & Technology, Novartis AG
Evangelia Tzika, VC Associate, Modi Ventures
Tatjana Uffelmann, Senior Scientist, Novartis
Laura Unmuth, Bench Scientist & PhD candidate - Antibody Discovery & Protein Engineering, Merck KGaA
Katharina Urban, Senior Scientist, Panosome
Stefanie Urlinger, Chief Scientific Officer, Cimeio Therapeutics
Thomas Valerius, Assistant Professor, Section For Stem Cell Transplantation And Immunotherapy, University of Kiel
Samya Van Coillie, Scientist in Research & Discovery, argenx
Joshi Venugopal, Global Head Drug Development Operation Ex, Novartis
Joey Verdi, CSO, Panosome GmbH
Wouter Verdurmen, Assistant Professor, Radboud University Nijmegen Medical Centre
Thomas Vincent, VP, Antibody Discovery, Alloy Therapeutics
Pieter Voermans, Head CDM, Sobi
Annette Vogl, VP, Biology and Translational Research, Tubulis GmbH
Bjørn Voldborg, Head of the National Biologics Facility, Danish Technical University
Johannes vom Berg, PI, University of Zurich
Romain Vuillefroy de Silly, Senior Scientist, University of lausanne
Daniel Waldera-Lupa, Associate Director Analytical Development, ProtaGene
Frank Walsh, Chief Executive Officer, Ossianix, Inc.
David Walter, Group leader, Cancer Research Horizons
Jianyong Wang, Senior Principal Scientist, Genentech
Andreas Weise, Senior Account Manager, Genovac Antibody Discovery
Theodora Weisz, Head of Patient Advocacy and Public Affairs, Novartis
Jörg Wischhusen, Professor, Universitätsklinikum Würzburg
Frederick Wittke, Vaccines Clinical Development Team Lead Europe, Independent
Artur Yakimovich, Young Investigator Group Leader, Helmholtz-Zentrum Dresden-Rossendorf
Yi-Ru Yu, Lead Scientist, Pilatus Biosciences SA
Michael Zaiac, Head of Medical Affairs Oncology Europe and Canada, Daiichi Sankyo
Joe Zhao, Vice President, Head of External Innovation, Nona Biosciences
Dr Hang Zhou, Head of Bioprocess R&D, WuXi Biologics
Marie Zhu, CTO, WuXi XDC
Bettina Ziegele, Head Innovation Office, Paul Ehrlich Institute
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events